A Recap of Ax-S Thursdays Session #1
![](https://axspharma.com/wp-content/uploads/2021/02/axs-thursdays-conference-series.jpg)
On Thursday, February 11, 2021, a panel of Healthcare leaders answered an important question: How well have we utilized existing pathways to make new COVID-19 medicines available in healthcare prior to their full marketing approval? Different countries have their own versions of the “Emergency Use Authorization”, but there are also “Expanded Access Programs” which are […]